![](/img/cover-not-exists.png)
O-108 Randomized phase III trial of chemotherapy and antisense oligonucleotide LY900003 (ISIS 3521) in patients with advanced NSCLC
Lynch, Thomas James, Raju, R., Lind, M., Riviere, A., Gatzemeier, U., Dorr, A., Holmlund, J., Yuen, A., Sikic, B.Volume:
41
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(03)91766-1
Date:
August, 2003
File:
PDF, 189 KB
english, 2003